U.S. markets closed

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.6000-0.0150 (-2.44%)
At close: 8:00AM CET
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.6150
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.6000 - 0.6000
52 Week Range0.1590 - 0.7150
Avg. Volume183
Market Cap21.014M
Beta (5Y Monthly)1.27
PE Ratio (TTM)N/A
EPS (TTM)-0.0870
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Newsfile

      Canntab Engages Independent Trading Group for Market Making Services

      Toronto, Ontario--(Newsfile Corp. - February 17, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced today that it has engaged Independent Trading Group Inc. ("ITG") to provide market-making services to the Company. ITG will trade the Company's common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE") and other marketplaces, ...

    • Hot quiz for couples in lockdown on Valentine's Day
      CNW Group

      Hot quiz for couples in lockdown on Valentine's Day

      10, 2021 /CNW/ -- AirConsole launches a hot new quiz for couples that are caught in lockdown for Valentine's Day 2021 due to the ongoing pandemic. This year, you will truly get to know your partner.

    • Newsfile

      Canntab Grants Options

      Toronto, Ontario--(Newsfile Corp. - February 3, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab") announces that it has granted, in accordance with the Company's stock option plan, an aggregate of 50,000 options to purchase common shares of the Company to a consultant of the Company. Each option is exercisable at a price of $0.80 per share for a period of two years, expiring February 3, 2023.About ...